| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
-Radiation-induced T-cell Lymphomas1
Departamento de Biologia, Laboratorio de Genética Molecular Humana, Facultad de Ciencias, Universidad Autónoma de Madrid, 28049-Madrid, Spain [M. H., J. S., J. F-P.]; Unidad de Investigación, Hospital Universitario, Universidad de La Laguna, 38071-Tenerife, Spain [E. S.]; and Departamento de Inmunologia y Oncologia, Centro Nacional de Biotecnologia, 28049-Madrid, Spain [M. S.]
We have isolated and sequenced a DNA fragment of about 12 kb that comprises exons 514 of the mouse p73 gene. We have identified four polymorphic markers, and one of them has been used to genetically map p73 to the distal part of chromosome 4. Previously, we have reported that
-radiation-induced T-cell lymphomas undergo frequent loss of heterozygosity around marker D4Mit205b at the distal part of chromosome 4. Based on this, we have performed loss of heterozygosity analysis in a set of T-cell lymphomas, and we have found allelic losses of p73 in 32.6% (16 of 49) of the tumors analyzed. Interestingly, allelic losses occur concurrently at both p73 and D4Mit205b, thus suggesting that p73 could be specifically inactivated in radiation-induced T-cell lymphomas.
This article has been cited by other articles:
![]() |
M.M. de Yzaguirre, J.S. Hernandez, P.F. Navarro, P.L. Nieva, M. Herranz, M.F. Fraga, M. Esteller, A. Juarranz, and J. Fernandez-Piqueras Epigenetic silencing of E- and N-cadherins in the stroma of mouse thymic lymphomas Carcinogenesis, May 1, 2006; 27(5): 1081 - 1089. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. M. Moll and N. Slade p63 and p73: Roles in Development and Tumor Formation Mol. Cancer Res., July 1, 2004; 2(7): 371 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lopez-Nieva, J. Santos, and J. Fernandez-Piqueras Defective expression of Notch1 and Notch2 in connection to alterations of c-Myc and Ikaros in {gamma}-radiation-induced mouse thymic lymphomas Carcinogenesis, July 1, 2004; 25(7): 1299 - 1304. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. M. Moll The Role of p63 and p73 in Tumor Formation and Progression: Coming of Age Toward Clinical Usefulness: Commentary re: F. Koga et al., Impaired p63 Expression Associates with Poor Prognosis and Uroplakin III Expression in Invasive Urothelial Carcinoma of the Bladder. Clin. Cancer Res., 9: 5501-5507, 2003, and P. Puig et al., p73 Expression in Human Normal and Tumor Tissues: Loss of p73{alpha} Expression Is Associated with Tumor Progression in Bladder Cancer. Clin. Cancer Res., 9: 5642-5651, 2003. Clin. Cancer Res., November 15, 2003; 9(15): 5437 - 5441. [Full Text] [PDF] |
||||
![]() |
M. S. Irwin and W. G. Kaelin p53 Family Update: p73 and p63 Develop Their Own Identities Cell Growth Differ., July 1, 2001; 12(7): 337 - 349. [Full Text] [PDF] |
||||
![]() |
J. Mostecki, A. Halgren, A. Radfar, Z. Sachs, J. Ravitz, K. C. Thome, and N. Rosenberg Loss of Heterozygosity at the Ink4a/Arf Locus Facilitates Abelson Virus Transformation of Pre-B Cells J. Virol., October 15, 2000; 74(20): 9479 - 9487. [Abstract] [Full Text] |
||||
![]() |
I. Lemasson and J. K. Nyborg Human T-cell Leukemia Virus Type I Tax Repression of p73beta Is Mediated through Competition for the C/H1 Domain of CBP J. Biol. Chem., May 4, 2001; 276(19): 15720 - 15727. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |